1.Expert consensus on precision detection of intrahepatic cholangiocarcinoma (2024 edition)
, Shanghai 200032, China PATHOLOGY GROUP, CHINESE SOCIETY OF LIVER CANCER OF CHINESE ANTI-CANCER ASSOCIATION ; LIVER PATHOLOGY GROUP, CHINESE SOCIETY OF PATHOLOGY OF CHINESE ANTI-CANCER ASSOCIATION ; TUMOR PATHOLOGY COMMITTEE OF SHANGHAI ANTI-CANCER ASSOCIATION
Chinese Journal of Clinical Medicine 2025;32(1):145-160
Intrahepatic cholangiocarcinoma (ICC) is a highly heterogeneous tumor, and molecular profiling serves as the foundation for personalized treatment of ICC. Accurate detection methods are clinically significant for comprehensively screening patients suitable for targeted therapies. This consensus is based on clinical practice data from both domestic and international sources, tailored to the Chinese context, and focuses on key targets for ICC. We present 15 recommendations aimed at guiding the precision detection of ICC.
2.Evidence-based practice guidelines for standardized pathological diagnosis of primary liver cancer in China: 2015 update
Chinese Society of Liver Cancer,Chinese Anti-Cance ; Liver Cancer Study Group, Chinese Society of Hepat ; Chinese Society of Pathology,Chinese Anti-Cancer A ; Digestive Disease Group, Chinese Society of Pathol ; Hepatic Surgery Group, Chinese Society of Surgery, ; Chinese Society of Clinical Oncology,Chinese Anti- ; Chinese Pathological Group of Hepatobiliary Tumor
Chinese Journal of Hepatology 2015;23(5):321-327
Result Analysis
Print
Save
E-mail